KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Equity Ratio: 2010-2015

Historic Equity Ratio for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to 0.46.

  • Biocryst Pharmaceuticals' Equity Ratio fell 24.27% to 0.46 in Q3 2015 from the same period last year, while for Sep 2015 it was 0.46, marking a year-over-year decrease of 24.27%. This contributed to the annual value of 0.55 for FY2014, which is 2498.12% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Equity Ratio of 0.46 as of Q3 2015, which was down 9.03% from 0.51 recorded in Q2 2015.
  • Biocryst Pharmaceuticals' 5-year Equity Ratio high stood at 0.63 for Q2 2014, and its period low was -0.23 during Q2 2013.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Equity Ratio value was 0.46 (recorded in 2015), while the average stood at 0.26.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Equity Ratio plummeted by 210.35% in 2013, and later surged by 2,498.12% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.18 in 2011, then plummeted by 104.39% to -0.01 in 2012, then plummeted by 191.53% to -0.02 in 2013, then surged by 2,498.12% to 0.55 in 2014, then dropped by 24.27% to 0.46 in 2015.
  • Its Equity Ratio was 0.46 in Q3 2015, compared to 0.51 in Q2 2015 and 0.50 in Q1 2015.